शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
Announced Mon, 10 Nov, 2025 · 21:49 IST

IREDA board approves internal promotions and CRO tenure extension

IREDA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹148.99
prior close
₹148.90
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.4%-0.3% vs market
Financial Institution peers, median of 7sector-0.9%+1.0% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Midcap 150 and 1.0 pts more than its Financial Institution peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-0.3
15m
-0.8
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2+0.4-0.3-0.9+1.0
Next day
+1.3+1.2+0.1-0.2+1.5
2d
+0.4+0.9-0.5-0.2+0.6
3d
+0.5+0.9-0.4-0.6+1.1
4d
+1.4+1.6-0.2+0.1+1.4
5d
-0.6+1.0-1.5-0.9+0.4
1w
-1.5+1.3-2.7-1.0-0.4
15d
-5.7+0.9-6.6-4.5-1.3
1m
-9.7-1.1-8.7-8.9-0.8
2m
-4.7-0.8-3.9-1.4-3.4
3m
-15.0+1.1-16.1-2.3-12.7
UpDownMarket · Nifty Midcap 150Sector · Financial Institution peers, median of 7Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

IREDA's board approved four internal management changes on November 10, 2025. Chief Risk Officer Pallav Kapoor received a three-year tenure extension until October 31, 2028. Three senior employees were promoted: A. Chandrashekar and K P Philip to General Manager (Projects), and Sanjay Kumar to Additional General Manager (IT). All three continue in their existing responsibilities including Internal Audit and CISO roles.

Likely market impact

Routine internal promotions and a CRO tenure extension. No material impact on operations or shareholders expected.